We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Declaration of voting rights - Valneva SE, March 2024 VALNEVA Declaration of shares and voting rights March 31, 2024___________________________________________________________________________...
Valneva lance un essai de Phase 1 sur son candidat vaccin de deuxième génération contre le virus Zika Saint-Herblain (France), le 26 mars 2024 – Valneva SE (Nasdaq : VALN ; Euronext Paris :...
Valneva annonce le dépôt de son Document d’Enregistrement Universel 2023 et de son rapport annuel américain « Form 20-F » Saint-Herblain (France), 25 mars 2024 – Valneva SE (Nasdaq : VALN;...
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F Saint-Herblain (France), March 25, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C. Saint-Herblain (France), March 21, 2024 – Valneva...
Total revenues of €153.7 million, including product sales of €144.6 million Product sales surpassed pre-pandemic (2019) sales by 12% and 2022 sales by 26%Excluding COVID-19 vaccine sales, product...
Valneva annonce un report de la date de début de remboursement du prêt contracté avec les sociétés Deerfield et OrbiMed Les remboursements sont différés de 18 mois et débuteront en janvier...
VALNEVA Declaration of shares and voting rights - February 29, 2024 VALNEVA Declaration of shares and voting rights February 29, 2024_______________________________________________________...
Déclaration d’actions et de droits de vote de la société Valneva - 29 février 2024 VALNEVA Déclaration d’actions et de droits de vote 29 février 2024___________________________________________...
Valneva fera une présentation lors des conférences investisseurs TD Cowen et Van Lanschot Kempen Saint-Herblain (France), 4 mars 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.166 | -4.59579180509 | 3.612 | 3.84 | 3.446 | 351373 | 3.60371276 | DE |
4 | -0.168 | -4.64858882125 | 3.614 | 4.264 | 3.446 | 493009 | 3.76867947 | DE |
12 | -0.244 | -6.61246612466 | 3.69 | 4.264 | 2.95 | 540968 | 3.52431562 | DE |
26 | -1.718 | -33.2687838885 | 5.164 | 7.168 | 2.95 | 480922 | 4.2813116 | DE |
52 | -1.112 | -24.396665204 | 4.558 | 7.846 | 2.95 | 404278 | 5.0567255 | DE |
156 | -8.024 | -69.9564080209 | 11.47 | 29.7 | 2.95 | 755785 | 13.17038661 | DE |
260 | 0.056 | 1.65191740413 | 3.39 | 29.7 | 1.784 | 611145 | 11.73883824 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions